Back to News
Market Impact: 0.25
Treace Medical Concepts (TMCI) Reports Q3 Loss, Tops Revenue Estimates
Source: zacks.com
Corporate EarningsCompany FundamentalsAnalyst Estimates
Treace Medical Concepts reported a quarterly loss of $0.19 per share, narrower than the $0.26 loss forecast by the Zacks Consensus Estimate and the $0.26 loss a year earlier. The results indicate a modest earnings beat and year-over-year improvement.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
Ticker Sentiment
TMCI0.45
More News
- Further turmoil could be in store for tech stocks. What to watch in the week ahead
- Elon Musk once said the Cybertruck would be Tesla’s ‘best product ever.’ Now he’s winding down production
- AI stocks hammered by midterm shock as data center buildout becomes a 'war of attrition'
- Fox completes its $22B acquisition of Roku
- Elanco Shares Jump After Q3 Beat and Outlook Raise
- FTSE 100 today: Stocks slump as global tech rout deepens